AT525409A3 - Medizinisches Pflaster mit langsamer Freisetzung - Google Patents

Medizinisches Pflaster mit langsamer Freisetzung Download PDF

Info

Publication number
AT525409A3
AT525409A3 ATA9160/2021A AT91602021A AT525409A3 AT 525409 A3 AT525409 A3 AT 525409A3 AT 91602021 A AT91602021 A AT 91602021A AT 525409 A3 AT525409 A3 AT 525409A3
Authority
AT
Austria
Prior art keywords
medicated patch
slow release
sodium salt
release medicated
diclofenac
Prior art date
Application number
ATA9160/2021A
Other languages
English (en)
Other versions
AT525409A2 (de
Inventor
Pizzocaro Carlo
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of AT525409A2 publication Critical patent/AT525409A2/de
Publication of AT525409A3 publication Critical patent/AT525409A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)

Abstract

Es wird ein medizinisches Pflaster mit langsamer Freisetzung auf der Basis von Diclofenac beschrieben, insbesondere ein medizinisches Pflaster auf der Basis von Diclofenac-Natriumsalz, dessen Formulierung die kontinuierliche Freisetzung des Wirkstoffs in lokal therapeutisch wirksamen Konzentrationen über 24 Stunden ermöglicht, sowie die adhäsive Polymermatrix (PSA) zur Verwendung in einem medizinischen Pflaster auf der Basis von Diclofenac-Natriumsalz.
ATA9160/2021A 2020-05-20 2021-05-18 Medizinisches Pflaster mit langsamer Freisetzung AT525409A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102020000011686A IT202000011686A1 (it) 2020-05-20 2020-05-20 Cerotto medicato a lento rilascio
PCT/IB2021/054261 WO2021234562A1 (en) 2020-05-20 2021-05-18 Slow-release medical plaster

Publications (2)

Publication Number Publication Date
AT525409A2 AT525409A2 (de) 2023-03-15
AT525409A3 true AT525409A3 (de) 2023-04-15

Family

ID=71994907

Family Applications (1)

Application Number Title Priority Date Filing Date
ATA9160/2021A AT525409A3 (de) 2020-05-20 2021-05-18 Medizinisches Pflaster mit langsamer Freisetzung

Country Status (36)

Country Link
US (1) US20230190668A1 (de)
EP (1) EP4153151B1 (de)
KR (1) KR20230013033A (de)
CN (1) CN115666537B (de)
AR (1) AR122136A1 (de)
AT (1) AT525409A3 (de)
BE (1) BE1028251B1 (de)
CA (1) CA3178964A1 (de)
CH (1) CH718822B1 (de)
CZ (1) CZ2022461A3 (de)
DE (1) DE112021002871T5 (de)
DK (2) DK4153151T3 (de)
EE (1) EE05862B1 (de)
ES (2) ES2972189T3 (de)
FI (1) FI4153151T3 (de)
FR (1) FR3110397B1 (de)
GB (1) GB2610106B (de)
GR (1) GR1010304B (de)
HR (1) HRP20240192T1 (de)
HU (2) HU231555B1 (de)
IE (1) IE20210109A1 (de)
IT (1) IT202000011686A1 (de)
LT (1) LT4153151T (de)
LU (1) LU501245B1 (de)
MA (1) MA59594B1 (de)
MD (1) MD4153151T2 (de)
NL (1) NL2028233B1 (de)
PL (2) PL4153151T3 (de)
PT (2) PT4153151T (de)
RO (1) RO137440A2 (de)
RS (1) RS65194B1 (de)
SI (1) SI4153151T1 (de)
SK (1) SK289303B6 (de)
SM (1) SMT202400017T1 (de)
TR (1) TR2021008324A2 (de)
WO (1) WO2021234562A1 (de)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
WO2006097149A1 (en) * 2005-03-17 2006-09-21 Pharmafilm S.R.L. An aqueous polymeric system for pressure sensitive adhesive matrix preparation
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
WO2012089256A1 (en) * 2010-12-29 2012-07-05 Pharmafilm S.R.L. Medicated patch for improved transdermal permeation of diclofenac diethylammonium

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09208463A (ja) * 1996-02-07 1997-08-12 Tsumura & Co 経皮吸収性に優れた消炎鎮痛組成物
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
WO2004067678A1 (ja) * 2003-01-27 2004-08-12 Mitsubishi Corporation 抗酸化組成物と外用組成物
CN1215838C (zh) * 2003-06-25 2005-08-24 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
JP2014515365A (ja) * 2011-05-26 2014-06-30 ノバルティス アーゲー 生理学的活性剤の経皮投与のための組成物
JP5758050B2 (ja) * 2012-06-20 2015-08-05 久光製薬株式会社 貼付剤
ES2991296T3 (es) 2014-10-17 2024-12-03 Fidia Farm Spa Sistema terapéutico dérmico de alta adhesividad

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
WO2006097149A1 (en) * 2005-03-17 2006-09-21 Pharmafilm S.R.L. An aqueous polymeric system for pressure sensitive adhesive matrix preparation
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
WO2012089256A1 (en) * 2010-12-29 2012-07-05 Pharmafilm S.R.L. Medicated patch for improved transdermal permeation of diclofenac diethylammonium

Also Published As

Publication number Publication date
FR3110397A1 (fr) 2021-11-26
FR3110397B1 (fr) 2025-05-16
ES2936185R1 (es) 2023-10-11
ES2972189T3 (es) 2024-06-11
TR2021008324A2 (tr) 2021-12-21
GB2610106A (en) 2023-02-22
EE05862B1 (et) 2024-01-15
LU501245B1 (fr) 2022-05-17
GR20210100319A (el) 2021-12-09
GB202217015D0 (en) 2022-12-28
CN115666537B (zh) 2025-10-17
PT2021234562B (pt) 2025-12-26
PT4153151T (pt) 2024-02-05
MA59594B1 (fr) 2024-03-29
CN115666537A (zh) 2023-01-31
RS65194B1 (sr) 2024-03-29
KR20230013033A (ko) 2023-01-26
CZ2022461A3 (cs) 2022-12-14
GR1010304B (el) 2022-09-28
LU501245A1 (fr) 2022-02-15
PL245596B1 (pl) 2024-09-02
NL2028233B1 (en) 2023-10-25
DK181719B1 (en) 2024-11-06
SK289303B6 (sk) 2025-03-26
EP4153151A1 (de) 2023-03-29
HUE066041T2 (hu) 2024-07-28
WO2021234562A1 (en) 2021-11-25
DK4153151T3 (da) 2024-02-05
HUP2200459A2 (hu) 2023-03-28
US20230190668A1 (en) 2023-06-22
EP4153151B1 (de) 2023-11-22
BE1028251A1 (fr) 2021-11-29
CH718822B1 (it) 2024-01-15
IE20210109A1 (en) 2022-08-17
RO137440A2 (ro) 2023-05-30
AR122136A1 (es) 2022-08-17
LT4153151T (lt) 2024-02-26
HRP20240192T1 (hr) 2024-05-10
NL2028233A (en) 2021-12-01
ES2936185B2 (es) 2025-06-12
GB2610106B (en) 2024-08-07
SK500562022A3 (sk) 2022-12-21
PL442805A1 (pl) 2023-07-03
IT202000011686A1 (it) 2021-11-20
ES2936185A2 (es) 2023-03-14
SI4153151T1 (sl) 2024-03-29
DE112021002871T5 (de) 2023-03-23
SMT202400017T1 (it) 2024-03-13
BE1028251B1 (fr) 2022-04-05
DK202201037A1 (en) 2022-11-21
FI4153151T3 (fi) 2024-02-08
HU231555B1 (hu) 2024-11-28
EE202200014A (et) 2022-12-15
AT525409A2 (de) 2023-03-15
MD4153151T2 (ro) 2024-04-30
PL4153151T3 (pl) 2024-04-22
CA3178964A1 (en) 2021-11-25

Similar Documents

Publication Publication Date Title
MX2023005362A (es) Proceso para hacer un inhibidor de proteina de muerte programada 1 (pd-1)/ligando de muerte programada 1 (pd-l1) y sales y formas cristalinas del mismo.
JOP20190257A1 (ar) مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats
BRPI0408690A (pt) composto, método para tratamento de uma doença, composição farmacêutica, e, uso de um composto
MX2007004862A (es) Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias.
CO2019010078A2 (es) Compuestos de pirimidinil-pyridiloxi-naftil y métodos para tratar enfermedades y trastornos relacionados con ire1
BR112018003823A2 (pt) compostos auxiliares inibidores de metaloproteinase de matriz para dispositivos cirúrgicos
KR101170705B1 (ko) 아크릴 폴리머계 접착제
MX2022014924A (es) Moduladores de il-17a.
KR20100044162A (ko) 손상 회복 조성물 및 방법
KR20140054248A (ko) 함수 첩부제
MX2022009961A (es) Método para producir biomaterial descelularizado, material descelularizado y usos de este.
MX2023005533A (es) Derivado de triazina diona, metodo de preparacion y aplicacion del mismo en medicina.
BRPI0512252A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
MX2021007161A (es) Agente que contiene acido ursodesoxicolico para tratar o prevenir la presbicia.
AT525409A3 (de) Medizinisches Pflaster mit langsamer Freisetzung
MX2007004861A (es) Derivados de sulfonamida novedosos como moduladores de receptor glucocorticoide para el tratamiento de enfermedades inflamatorias.
ATE550040T1 (de) Polymer-klebematrix mit salifizierten carboxylgruppen für die transdermale anwendung
MY204686A (en) Biocompatible polymeric coating containing therapeutic agents
DE60314779D1 (de) Piezoelektrische vorrichtung zur abgabe eines vaskulären implantats
KR101177718B1 (ko) 아크릴 폴리머계 접착제
BRPI0517369A (pt) compostos, processo para a sua manufatura, composições que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização
MX2023013616A (es) Composiciones para el tratamiento de condiciones neurodegenerativas.
ECSP24007193A (es) Compuestos pirimidínicos para usar como inhibidores de map4k1
BR112023024585A2 (pt) Adesivo de alívio da dor
EA201991280A1 (ru) Антисептическая композиция, содержащая унитиол и диметилсульфоксид, применение такой композиции и способ обработки ран с ее использованием